Kwality Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on December 22, 2016, has considered and approved interim dividend at the rate of 6% i.e. Re 0.60 per equity share of Rs 10 each on the equity share capital of the company for the year 2016-17. The Board Meeting commenced at 04:00 P.M and concluded at 05:45 P.M. The dividend is expected to be paid /dispatched as per applicable provisions of the SEBI (LODR) Regulations, 2015 and Companies Act, 2013.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: